An Early Phase 1 interventional study of Low dose ASA and Control in Aging, sponsored by Penn State University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-27.
Sponsored by Penn State University · Early Phase 1, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Heat Stress Disorders with a site in United States — 11 open to participants now, 13 under way, none of them phase 3. Heat Stress Disorders · United States.
Among the 33 studies in Heat Stress Disorders with a site in United States, this one is the 2nd largest by planned enrollment of the 27 interventional ones that give a count, is the only one that started in 2020, is the only one in phase 1, reaches primary completion later than 6 of the 12 other live ones, and was the 8th registered.
118 studies on the registry are indexed under Heat Stress Disorders; 42 are open to participants now.
Browse Heat Stress Disorders studies →11 of the 33 studies in Heat Stress Disorders with a site in United States are open now. Recruiting first, the newest first:
Hartford Hospital · Sites in United States
Ages 18–25
The University of Texas Health Science Center at San Antonio · Sites in United States
Ages 18–60
University of Northern Iowa · Sites in United States
Ages 18–45 · Healthy volunteers
Providence College · Sites in United States
Ages 18–45 · Women only · Healthy volunteers
Harvard School of Public Health (HSPH) · Sites in United States
Ages 55–95
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 30 Heat Stress Disorders studies recruiting now, 8 (27%) set no upper age limit and 18 (60%) stop at 75 or younger; 6 take children under 18; 22 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 1 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 190 is above the median of 24 across 104 interventional studies indexed under Heat Stress Disorders.
Median enrollment 24 across the 27 interventional studies, 27 across the 6 observational. Of the 19 that completed or were terminated, 2 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 33 has an industry lead sponsor. The 10 most frequent:
Penn State University is the lead sponsor of 271 studies on the registry; 54 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 11 (73%) have results posted.
Penn State University has 4 studies filed under Heat Stress Disorders — fewer than ten, so there is no comparison to draw.
6 of the studies in Heat Stress Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03042988Vanderbilt University Medical CenterOvernight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension | 2026-11-30 |
| NCT06798571Penn State UniversityRole of Menopause in Thermoregulation | 2026-12-01 |
| NCT04284397Penn State UniversityIdentification of Critical Thermal Environments for Aged Adults | 2027-02-27 |
| NCT07472426University of Northern IowaEffects of Creatine Supplementation on Cognitive Measures and Markers of Acute Kidney Injury After Exercise in the Heat | 2027-03 |
| NCT06475339State University of New York at BuffaloPredicting Responses to Exhausting, Prolonged, And Repeated Exercise Demands (PREPARED) for Heat | 2027-03 |
Add all 6 to your calendar (.ics) → With an account.
Among the 33 studies in Heat Stress Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study evaluates critical environmental limits (temperature and humidity) above which older adults are unable to effectively thermoregulate. Participants will exercise in a series of different environmental conditions to identify combinations of temperature and humidity above which age-related physiological changes cause uncompensable heat stress, resulting in increased risk of heat illness.
The earth's climate is warming well above historical averages, and there is an increased frequency, duration, and severity of heat waves. At the same time, the world's population is rapidly aging. Aging is associated with reductions in thermoregulatory capacity due to reductions in sweating and skin blood flow. For this reason, people ≥65 years exhibit exponentially larger increases in morbidity and mortality during heat waves than younger individuals, with the large majority of excess deaths during heat waves occurring in the elderly.
Compounding the physiological effects of primary aging, co-morbidities and common classes of drugs taken by older adults can further compromise their thermoregulatory function. One such class of medications is cyclooxygenase inhibitors, including aspirin (ASA) and other platelet inhibitors. Provocative data published by our lab indicate that platelet inhibitors including ASA increase the rate of heat storage during passive heat stress by \~25%. Following current clinical guidelines, nearly 40% of US adults over the age of 50 engage in an aspirin therapy regiment for the primary or secondary prevention of cardiovascular disease.
Although there is compelling evidence that aging is associated with decreased heat dissipation and elevated risk of heat illness in hot ambient conditions, the significant question remains: In what specific environments does this age disparity begin to occur? The goal of the current study is to identify and model ambient conditions that are unsafe for older adults. A second aim of the study is to determine the effects of the commonly used platelet inhibitor, acetylsalicylic acid (ASA), on age-specific critical environmental limits.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects will perform exercise at \~200-300W with ambient temperature or humidity increasing every 5 min throughout the trial until core temperature begins to rise.
Other: Control
After a minimum of 7 days of daily, low-dose aspirin ingestion, older subjects will repeat critical environmental limits trials. As before, subjects will perform exercise at \~200-300W with ambient temperature or humidity increasing every 5 min throughout the trial until core temperature begins to rise.
Drug: Low dose ASA
A sub-group of older adults will be re-tested after 7 days of treatment with low-dose aspirin.
Also known as: Low-dose aspirin
All participants will be tested with no treatment.
Temperature and humidity limits for maintaining stable core temperature
Core temperature will be measured throughout exercise. The point at which heat stress becomes uncompensable will be determined for each environmental and exercise condition by assessing the combination of temperature and humidity at which core temperature begins to rise.
Time frame: Through study completion, an average of 1 year.
Core temperature
Core temperature will be monitored throughout each experimental visit
Time frame: Continuous throughout visit until completion of exercise; an average of 2 hours.
Sweat rate
Sweat rate will be determined by measuring nude body mass before and after each experimental visit
Time frame: Immediately before and immediately after exercise.
Skin temperature
Skin temperature will be monitored throughout each experimental visit
Time frame: Continuous throughout visit until completion of exercise; an average of 2 hours.
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2020 (actual). Primary completion is estimated for Feb 2027, 73 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Aspirin